Correlation Between Novo Nordisk and Verve Therapeutics
Can any of the company-specific risk be diversified away by investing in both Novo Nordisk and Verve Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Novo Nordisk and Verve Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Novo Nordisk AS and Verve Therapeutics, you can compare the effects of market volatilities on Novo Nordisk and Verve Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Novo Nordisk with a short position of Verve Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Novo Nordisk and Verve Therapeutics.
Diversification Opportunities for Novo Nordisk and Verve Therapeutics
0.14 | Correlation Coefficient |
Average diversification
The 3 months correlation between Novo and Verve is 0.14. Overlapping area represents the amount of risk that can be diversified away by holding Novo Nordisk AS and Verve Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Verve Therapeutics and Novo Nordisk is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Novo Nordisk AS are associated (or correlated) with Verve Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Verve Therapeutics has no effect on the direction of Novo Nordisk i.e., Novo Nordisk and Verve Therapeutics go up and down completely randomly.
Pair Corralation between Novo Nordisk and Verve Therapeutics
Considering the 90-day investment horizon Novo Nordisk AS is expected to under-perform the Verve Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Novo Nordisk AS is 2.82 times less risky than Verve Therapeutics. The stock trades about -0.14 of its potential returns per unit of risk. The Verve Therapeutics is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest 579.00 in Verve Therapeutics on August 31, 2024 and sell it today you would lose (1.00) from holding Verve Therapeutics or give up 0.17% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Novo Nordisk AS vs. Verve Therapeutics
Performance |
| Timeline |
| Novo Nordisk AS |
| Verve Therapeutics |
Novo Nordisk and Verve Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Novo Nordisk and Verve Therapeutics
The main advantage of trading using opposite Novo Nordisk and Verve Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Novo Nordisk position performs unexpectedly, Verve Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Verve Therapeutics will offset losses from the drop in Verve Therapeutics' long position.| Novo Nordisk vs. Regeneron Pharmaceuticals | Novo Nordisk vs. Crispr Therapeutics AG | Novo Nordisk vs. Sarepta Therapeutics | Novo Nordisk vs. Intellia Therapeutics |
| Verve Therapeutics vs. Adaptive Biotechnologies Corp | Verve Therapeutics vs. Beam Therapeutics | Verve Therapeutics vs. Caribou Biosciences | Verve Therapeutics vs. Sana Biotechnology |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Other Complementary Tools
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |